HB 2163 Virginia House of Delegates · 2017 Regular Session

Buprenorphine without naloxone; prescription limitation.

Summary

Provides that prescriptions for products containing buprenorphine without naloxone shall be issued only (i) for patients who are pregnant, (ii) when converting a patient from methadone to buprenorphine containing naloxone for a period not to exceed seven days, or (iii) as permitted by regulations of the Board of Medicine or the Board of Nursing. The bill contains an emergency clause and has an expiration date of July 1, 2022. This bill is identical to

Bill status passed 4 of 5 stages cleared

Introduction

Jan 2017

Committee Review

Feb 2017

House of Delegates Passage

Apr 2017

Senate Passage

Jan 2017

Governor

Introduced Jan 11, 2017 Last action Apr 5, 2017

Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).

Full legislative history

Actions timeline

Total actions

Key actions

Committee

Apr 5, 2017

Executive · Passed

Governor's recommendation adopted

executive

Apr 5, 2017

Legislature · Passed

House concurred in Governor's recommendation (100-Y 0-N)

legislature

Feb 13, 2017

Legislature · Passed

Engrossed by Senate - committee substitute HB2163S1

legislature

Feb 13, 2017

Legislature · Passed

Committee substitute agreed to 17105325D-S1

legislature

Feb 1, 2017

Committee

Referred to Committee on Education and Health

legislature

Jan 31, 2017

Legislature · Passed

Read third time and passed House BLOCK VOTE (97-Y 0-N)

legislature

Jan 30, 2017

Legislature · Passed

Engrossed by House - committee substitute HB2163H1

legislature

Jan 30, 2017

Legislature · Passed

Committee substitute agreed to 17104675D-H1

legislature

Jan 17, 2017

Committee

Assigned HWI sub: Subcommittee #1

legislature

Jan 11, 2017

Committee

Referred to Committee on Health, Welfare and Institutions

legislature

Jan 11, 2017

Introduced

Prefiled and ordered printed; offered 01/11/17 17100981D

legislature

1 primary · 7 co-sponsors